NCT00272103View on ClinicalTrials.gov

Itopride in Functional Dyspepsia:a Dose Finding Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

December 31, 2000

Study Completion Date

January 31, 2002

Conditions
Functional Dyspepsia
Interventions
DRUG

Itopride (drug)

Trial Locations (1)

45122

University Hospital Essen, Essen

All Listed Sponsors
collaborator

Knoll Pharmaceuticals, Germany (now Abbott)

UNKNOWN

collaborator

University Hospital, Essen

OTHER

lead

Royal Adelaide Hospital

OTHER

NCT00272103 - Itopride in Functional Dyspepsia:a Dose Finding Study | Biotech Hunter | Biotech Hunter